EyePoint's Duravyu: Advancing Wet AMD Treatment with Completed Phase III & Sustained Delivery Breakthroughs

Clinical TrialsFDAMedical Researchers
Written By Corey Hubbard
EyePoint's Duravyu: Advancing Wet AMD Treatment
Glassbury Team

GlassBury Cares Podcast

Episode #24

Corey Hubbard
Previous

Walgreens Clinical Trials: Elevating Research, Empowering Diversity with AI & Unrivaled Access
Next

Viatris' Blepharitis Ointment Fails Phase III: Full Disclosure on Clinical Setback & Its Future